Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnWeb3SquareMore
Trade
Spot
Buy and sell crypto with ease
Margin
Amplify your capital and maximize fund efficiency
Onchain
Going Onchain, without going Onchain!
Convert
Zero fees, no slippage
Explore
Launchhub
Gain the edge early and start winning
Copy
Copy elite trader with one click
Bots
Simple, fast, and reliable AI trading bot
Trade
USDT-M Futures
Futures settled in USDT
USDC-M Futures
Futures settled in USDC
Coin-M Futures
Futures settled in cryptocurrencies
Explore
Futures guide
A beginner-to-advanced journey in futures trading
Futures promotions
Generous rewards await
Overview
A variety of products to grow your assets
Simple Earn
Deposit and withdraw anytime to earn flexible returns with zero risk
On-chain Earn
Earn profits daily without risking principal
Structured Earn
Robust financial innovation to navigate market swings
VIP and Wealth Management
Premium services for smart wealth management
Loans
Flexible borrowing with high fund security
Is France Sliding into an "Italian-Style" Crisis? Prime Minister Faces No-Confidence Vote as Political Turmoil Intensifies

Is France Sliding into an "Italian-Style" Crisis? Prime Minister Faces No-Confidence Vote as Political Turmoil Intensifies

Jin10Jin102025/09/01 11:51
Show original
By:Jin10

Four prime ministers in just a year and a half! France has fallen into a vicious cycle of being "ungovernable," and the current prime minister may step down again this week...

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!

You may also like

Convano’s $3 Billion Bitcoin Treasury Play: A High-Risk, High-Reward Macro Bet in a Weak Yen Environment

- Japanese firm Convano Inc. is allocating $3B to Bitcoin, aiming to hedge against yen depreciation and near-zero interest rates by acquiring 21,000 BTC (0.1% of total supply) by 2027. - The leveraged strategy mirrors moves by Metaplanet and MicroStrategy, using equity/debt financing to accelerate crypto accumulation amid Japan's 260% debt-to-GDP ratio and 15% yen depreciation in 2025. - Critics warn of "death spiral" risks: a 30% BTC price drop could erase $900M from Convano's investment, triggering force

ainvest2025/09/01 15:25
Convano’s $3 Billion Bitcoin Treasury Play: A High-Risk, High-Reward Macro Bet in a Weak Yen Environment

BitMine’s 5% Ethereum Supply Play: A New Sovereign Put for Institutional Crypto Exposure

- BitMine Immersion targets 5% of Ethereum's supply ($8.8B) to create a "sovereign put" mechanism stabilizing ETH prices and enhancing institutional utility. - The strategy combines staking yields (4-6% annualized) and a $24.5B equity program to generate compounding treasury growth through a flywheel effect. - Weekly ETH purchases (~190,500 tokens) reinforce Ethereum's deflationary dynamics, reducing downside risk for holders and boosting institutional confidence. - Post-2025 regulatory clarity and Ethereu

ainvest2025/09/01 15:25
BitMine’s 5% Ethereum Supply Play: A New Sovereign Put for Institutional Crypto Exposure

Solana's $88M Whale Accumulation and the Road to $250: On-Chain Confidence and Institutional Conviction

- Solana whales accumulated $88M in 3 days, signaling reduced sell pressure and potential $250 price test. - 13 institutions injected $1.72B into Solana treasuries, leveraging 7-8% staking yields amid ETF approval speculation. - SEC's October 2025 ETF decision could unlock $3.8B-$7.2B in institutional capital, mirroring Bitcoin's ETF surge. - Alpenglow upgrades and $553.8M RWA growth support bullish technical indicators, with $500 price targets by year-end.

ainvest2025/09/01 15:25
Solana's $88M Whale Accumulation and the Road to $250: On-Chain Confidence and Institutional Conviction

"Trump-EU Pharma Deal Averts Tariff War, But Leaves Pricing Battle Unresolved"

- The Trump administration and EU agreed on a 15% tariff for brand-name drugs and APIs, with generics exempt, effective September 1, 2025. - The rate, lower than Trump’s initial 250% threat, avoids a tariff war but excludes Section 232 measures for other partners. - European firms face $19B annual costs, prompting stockpiling and U.S. manufacturing shifts, while U.S. consumers may see higher drug prices. - The deal leaves unresolved pricing disputes and supply chain vulnerabilities, with ongoing Section 23

ainvest2025/09/01 15:21
"Trump-EU Pharma Deal Averts Tariff War, But Leaves Pricing Battle Unresolved"